235 related articles for article (PubMed ID: 8187064)
1. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
2. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations.
Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y
Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185
[TBL] [Abstract][Full Text] [Related]
3. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
5. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
6. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
7. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
8. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
[TBL] [Abstract][Full Text] [Related]
9. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
11. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity in sporadic colorectal adenomas.
Saraga E; Bautista D; Dorta G; Chaubert P; Martin P; Sordat B; Protiva P; Blum A; Bosman F; Benhattar J
J Pathol; 1997 Mar; 181(3):281-6. PubMed ID: 9155713
[TBL] [Abstract][Full Text] [Related]
14. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
[TBL] [Abstract][Full Text] [Related]
15. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
16. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
17. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
18. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]